Provided by Tiger Fintech (Singapore) Pte. Ltd.

Rigel Pharmaceuticals

19.57
+0.16000.82%
Post-market: 19.570.00000.00%16:27 EDT
Volume:91.17K
Turnover:1.78M
Market Cap:349.66M
PE:19.77
High:19.86
Open:19.50
Low:19.11
Close:19.41
Loading ...

Rigel Announces Conference Call and Webcast to Report First Quarter 2025 Financial Results and Business Update

PR Newswire
·
Yesterday

Rigel (RIGL) Upgraded to Buy: What Does It Mean for the Stock?

Zacks
·
18 Apr

4 Healthcare Stocks to Buy as the Sector Faces Government Heat

Zacks
·
17 Apr

Rigel Pharmaceuticals, Inc. Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

PR Newswire
·
04 Apr

High Growth Tech Stocks in the US for April 2025

Simply Wall St.
·
04 Apr

BUZZ-Rigel climbs on blood disorder drug patent settlement

Reuters
·
27 Mar

Rigel Pharmaceuticals Settles Patent Litigation Over Tavalisse

MT Newswires Live
·
27 Mar

BRIEF-Rigel Announces Settlement Agreement Resolving TAVALISSE® (Fostamatinib Disodium Hexahydrate) Patent Litigation

Reuters
·
27 Mar

Rigel Pharmaceuticals Inc - Under Settlement, Annora to Sell Generic Tavalisse in Q2 2032 or Earlier

THOMSON REUTERS
·
27 Mar

Rigel Pharmaceuticals Inc - Co and Annora Terminate All Ongoing Litigation Regarding Tavalisse Patents

THOMSON REUTERS
·
27 Mar

Rigel Announces Settlement Agreement Resolving Tavalisse® (Fostamatinib Disodium Hexahydrate) Patent Litigation

THOMSON REUTERS
·
27 Mar

Rigel Announces Settlement Agreement Resolving TAVALISSE® (fostamatinib disodium hexahydrate) Patent Litigation

PR Newswire
·
27 Mar

Rigel Pharmaceuticals Appoints Dr. Frohlich to Board

TIPRANKS
·
11 Mar

Rigel Pharmaceuticals Full Year 2024 Earnings: EPS Beats Expectations

Simply Wall St.
·
11 Mar

BRIEF-Rigel appoints Mark W. Frohlich to its board

Reuters
·
11 Mar

Rigel Appoints Mark W. Frohlich, M.d. to Board of Directors

THOMSON REUTERS
·
10 Mar

Press Release: Rigel Appoints Mark W. Frohlich, M.D. to Board of Directors

Dow Jones
·
10 Mar

Rigel Pharmaceuticals, Inc. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next

Simply Wall St.
·
07 Mar

AXSM Settles Sunosi Patent Litigation With Hikma Pharmaceuticals

Zacks
·
06 Mar

Rigel Pharmaceuticals price target raised to $55 from $49 at Citi

TIPRANKS
·
06 Mar